Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02725710 · ClinicalTrials.gov registry record · Phase 2
Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
NCT02725710 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 96 participants.
The verdict
NCT02725710, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
Study Summary
This is a randomized controlled double-blind placebo-controlled trial evaluating the impact of gabapentin given preoperatively on perioperative pain scores for women receiving uterine aspiration between 6 and 14+6 weeks gestation. This study will be a trial included in a prospective meta-analysis evaluating the use of gabapentin on perioperative pain in the abortion setting.
Interventions
- DRUG Placebo
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-06-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02725710
The ClinicalTrials.gov registry entry for NCT02725710 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02725710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02725710 about?
NCT02725710 is a clinical study titled "Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration". This is a randomized controlled double-blind placebo-controlled trial evaluating the impact of gabapentin given preoperatively on perioperative pain scores for women receiving uterine aspiration between 6 and 14+6 weeks gestation. This study will be a trial included in a prospective meta-analysis ev...
What is the current status of trial NCT02725710?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2016-08. Estimated completion is 2018-06-14.
What interventions are being tested in trial NCT02725710?
The interventions under investigation include: Placebo (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT02725710?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.